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Abstract. 
 
During development, neuregulin-1 promotes
 
Schwann cell proliferation and survival; its role in later
events of Schwann cell differentiation, including my-
elination, is poorly understood. Accordingly, we have
examined the effects of neuregulin-1 on myelination
in neuron-Schwann cell cocultures. Glial growth factor
(GGF), a neuregulin-1 isoform, signiﬁcantly inhibited
myelination by preventing axonal segregation and en-
sheathment. Basal lamina formation was not affected.
Treatment of established myelinated cultures with
GGF resulted in striking demyelination that fre-
quently began at the paranodes and progressed to the
internode. Demyelination was dose dependent and ac-
companied by dedifferentiation of Schwann cells to a
promyelinating stage, as evidenced by reexpression of
the transcription factor suppressed cAMP-inducible
POU; a signiﬁcant proportion of cells with extensive
demyelination also proliferated. Two other Schwann
cell mitogens, ﬁbroblast growth factor-2 and transform-
 
ing growth factor-
 
b
 
, inhibited myelination but did not
cause demyelination, suggesting this effect is speciﬁc
to the neuregulins. The neuregulin receptor proteins,
erbB2 and erbB3, are expressed on ensheathing and
myelinating Schwann cells and rapidly phosphorylated
with GGF treatment. GGF treatment of myelinating
 
cultures also induced phosphorylation of phosphatidyl-
inositol 3-kinase, mitogen-activated protein kinase, and a
120-kD protein. These results suggest that neuronal mito-
gens, including the neuregulins, may inhibit myelination
during development and that activation of mitogen signal-
ing pathways may contribute to the initial demyelination
and subsequent Schwann cell proliferation observed in
various pathologic conditions.
Key words: Schwann cell • demyelination • mitogen •
neuregulin • erbB
 
Introduction
 
Schwann cell generation and differentiation are tightly
regulated by axons. During development, axons promote
Schwann cell proliferation via contact-dependent mitogen(s)
(Salzer et al., 1980); competition for limiting quantities of
neuron-derived trophic factors ensures that the number of
Schwann cells is matched to the number and length of axons
(reviewed in Jessen and Mirsky, 1998). Once a full comple-
ment of Schwann cells is generated, axons together with the
extracellular matrix promote Schwann cell differentiation,
regulating whether they ensheathe or myelinate axons (re-
viewed in Bunge et al., 1986). Conversely, axotomy initiates a
characteristic series of dramatic events in the distal stump,
collectively referred to as Wallerian degeneration, that in-
cludes the degeneration of axons and myelin sheaths and the
dedifferentiation and proliferation of Schwann cells (Scherer
and Salzer, 1996). While the molecular cues that regulate
Schwann cell generation have begun to emerge, the signals
that regulate Schwann cell differentiation and their response
to axotomy remain poorly understood.
Axons promote the generation of Schwann cells, in large
part, via the activity of the neuregulins (reviewed in
Adlkofer and Lai, 2000). The neuregulins are a family of al-
ternatively spliced, soluble and membrane-bound proteins
encoded by four known genes. Neuregulin-1, which was the
first member of this family to be described and remains the
best characterized, is highly expressed by peripheral ner-
vous system and central nervous system neurons during
development (Garratt et al., 2000a). Studies with the sol-
 
uble neuregulin-1 isoform, glial growth factor (GGF),
 
1
 
indicate that this gene family can restrict neural crest
cells to the glial lineage (Shah et al., 1994) and promote
the maturation, proliferation, and survival of Schwann
cell precursors (Dong et al., 1995). Similarly, neuregulin-1
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promotes the proliferation (Morrissey et al., 1995) and
survival (Grinspan et al., 1996; Syroid et al., 1996; Trach-
tenberg and Thompson, 1996) of committed Schwann
cells associated with axons. In striking confirmation of its
importance in Schwann cell development, mice with tar-
geted disruptions of the neuregulin-1 gene (Meyer and
Birchmeier, 1995), or a major isoform expressed on pe-
ripheral nerves (Wolpowitz et al., 2000), exhibit a severe
deficiency of precursors or of committed Schwann cells,
respectively.
Neuregulin-1 isoforms mediate their effects by binding
to, and activating, members of the erbB receptor tyrosine
kinase family, which includes the EGF receptor (erbB1),
erbB2, erbB3, and erbB4 (reviewed in Adlkofer and Lai,
2000). Ligand binding is believed to result in receptor
dimerization, tyrosine phosphorylation, and subsequent
activation of intracellular signaling pathways (reviewed in
Burden and Yarden, 1997). ErbB2 and erbB3 are the ma-
jor receptor proteins expressed by Schwann cells and their
precursors during peripheral nerve development (Cohen
et al., 1992; Shah et al., 1994; Levi et al., 1995). Consistent
with their critical role, Schwann cells fail to develop in pe-
ripheral nerves of mice with knockouts of either erbB2 or
erbB3 (for a recent review, see Garratt et al., 2000a).
While the role of neuregulin-1 in early Schwann cell de-
velopment is well documented, its role in later events of
Schwann cell differentiation, including myelination, is less
clear. Neuregulin-1 continues to be expressed at signifi-
cant levels by neurons in the adult nervous system (Chen
et al., 1994), including motor and large sensory neurons
(Bermingham-McDonogh et al., 1997). These findings are
consistent with a functional role in the adult that includes
maintenance of neuromuscular junctions (Sandrock et al.,
1997) and, possibly, of myelin sheaths. Indeed, recent
studies in which the erbB2 gene was conditionally ablated
in developing Schwann cells provide evidence that this
neuregulin receptor subunit is important for myelination
(Garratt et al., 2000b). In potential agreement, neurons ac-
tivate phosphatidylinositol (PI) 3-kinase in Schwann cells
via neuregulin-1 and this activity, in turn, is required for
the generation of Schwann cells and the early events of
myelination (Maurel and Salzer, 2000). A potential limita-
tion of both studies is that they do not distinguish between
a role of neuregulin signaling in the initial axon–Schwann
cell interactions required for subsequent events of my-
elination versus a direct effect on myelination itself.
Accordingly, we have examined the effects of the neu-
regulin-1 isoform, GGF, on the differentiation and my-
elination of rat Schwann cells cultured with dorsal root
ganglion neurons. We now report that addition of GGF to
such cultures potently blocks myelination in a dose-
dependent manner. Addition of GGF to cultures in which
myelin had already formed results in striking demyelina-
tion associated with Schwann cell dedifferentiation and
proliferation. ErbB2 and erbB3 are rapidly phosphory-
lated and PI 3-kinase and mitogen-activated protein
(MAP) kinase are rapidly activated at the onset of GGF-
induced demyelination. These results suggest a novel
mechanism of demyelination in which activation of mito-
gen signaling pathways by neuregulin-1, and possibly
other mitogens, leads to myelin breakdown and Schwann
cell dedifferentiation.
 
Materials and Methods
 
Antibodies and Immunofluorescence
 
Mouse mAb included the anti–myelin-associated glycoprotein MA 513 (gift
of J. Roder, Mt. Sinai Hospital, Toronto, Ontario, Canada), anti–myelin ba-
sic protein (MBP) SMI 94 (Sternberger Monoclonals, Inc.), anti–phospho-
tyrosine RC20 (Transduction Laboratories, Inc.), and anti-BrdU 1202693
(Roche Molecular Biochemicals). Rabbit polyclonal antibodies included
anti–MBP (gift of D. Colman, Mt. Sinai Medical Center, New York, NY),
antilaminin L-9393 (Sigma-Aldrich), anti–erbB2 sc-284, anti–erbB3 sc-285
(Santa Cruz Biotechnology, Inc.), and anti–suppressed cAMP-inducible
POU (SCIP) 3-145 (gift of G. Lemke, The Salk Institute, La Jolla, CA). Sec-
ondary antibodies included affinity-purified, rhodamine-conjugated donkey
anti–rabbit IgG, fluorescein-conjugated donkey anti–mouse IgG (Chemi-
con International, Inc.) and HRP-conjugated goat anti–rabbit IgG (Amer-
sham Pharmacia Biotech). Cultures were processed for immunofluores-
cence microscopy as described previously (Einheber et al., 1995).
To quantitate the extent of myelination, the total number of myelin
sheaths was counted in each of six random 40
 
3
 
 fields per coverslip (12
fields per condition per experiment, total of two experiments). To quanti-
tate the extent of demyelination, the total numbers of normal and dam-
aged myelin sheaths were counted in each of six random 40
 
3
 
 fields per
coverslip (12 fields per condition per experiment, total of two experi-
ments). Myelin sheaths were classified as damaged if they contained vesi-
cles or if the sheaths were crenated or split.
 
Cell Culture
 
Rat Schwann cells and embryonic day 16 dorsal root ganglion (DRG)
neurons were isolated as described (Einheber et al., 1995). Neurons were
plated in C media, consisting of MEM (Life Technologies), 10% FBS (Hy-
Clone Laboratories), 4 mg/ml glucose (Sigma-Aldrich), 2 mM glutamine
(Life Technologies), and 50 ng/ml NGF (Harlan Bioproducts for Science).
Cultures were cycled on C media supplemented with 5-fluorodeoxyuri-
dine and uridine (Sigma-Aldrich), both at 10
 
2
 
5
 
 M, every other feeding for
2.5 wk to remove nonneuronal cells. Schwann cell-neuron cocultures were
prepared by adding 200,000 Schwann cells to each coverslip of purified
neurons. The next day, the media was replaced with N2 media (Botten-
stein and Sato, 1979) supplemented with 50 ng/ml NGF. The cocultures
were kept in N2 media for 3 d to allow the Schwann cells to repopulate the
neurites. To initiate basal lamina formation and myelination, some of the
cocultures were treated for 3–4 wk with C media supplemented with 50
 
m
 
g/ml ascorbic acid (Sigma-Aldrich). To generate premyelinated cocul-
tures, other cocultures were switched from N2 media to C media and
maintained in this media for 3–4 wk.
 
Electron Microscopy
 
In some cases, cultures treated with GGF were processed for and ana-
lyzed by electron microscopy. DRG neurons were cultured on Aclar (Al-
lied Signal) plastic coverslips for 2.5 wk, seeded with Schwann cells, and
switched to N2 media for 3 d. Some of the cocultures were then treated
with C media supplemented with ascorbic acid with or without 200 ng/ml
GGF and maintained for 7 d. Other cocultures were treated with C media
supplemented with ascorbic acid for 21 d to allow myelination to occur.
These cocultures were then treated for 3 d with C media supplemented
with ascorbic acid with or without 200 ng/ml GGF. All of the cocultures
were fixed, embedded in Epon-araldite and processed for electron micros-
copy as described (Einheber et al., 1995).
 
Proliferation Assays
 
To determine the relationship between Schwann cell proliferation and demy-
elination in Schwann cell-DRG neuron cocultures, myelinated cocultures
were treated with 200 ng/ml GGF for 36 or 48 h in the continuous presence
of 20 
 
m
 
M BrdU. The cocultures were fixed and stained for MBP and fixed
again and processed for anti–BrdU labeling as previously described (Maurel
and Salzer, 2000). Six random fields were photographed per coverslip (12
fields per condition per experiment, total of two experiments); BrdU- and
Hoechst-labeled nuclei in each field were counted. All of the myelin sheaths
in each field were also counted and characterized as either “not demy-
elinated,” “moderately demyelinated” if up to half of the myelin sheath was
damaged, or “extensively demyelinated” if more than half of the myelin
sheath was damaged. A Schwann cell nucleus was considered to be associ- 
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ated with an internode if it directly abutted a myelin sheath. Student’s 
 
t
 
 tests
were performed with the Statview software package (SAS Institute, Inc.).
 
Western Blots
 
ErbB2 and erbB3 levels, and the effects of GGF on erbB phosphorylation,
were determined by Western blot analysis as described (Canoll et al.,
1996). In brief, cultures of Schwann cells, neurons, premyelinated, and
myelinated cocultures were lysed after treating with or without 200 ng/ml
GGF for 2.5 min at 37
 
8
 
C, in chilled lysis buffer (Canoll et al., 1996). Simi-
larly, myelinated cocultures were lysed directly or after treatment with 20
or 200 ng/ml GGF for 3 d. Protein concentrations were determined by the
Micro BCA method (Pierce Chemical Co.). 15 
 
m
 
g of protein were frac-
tionated by SDS-PAGE, electroblotted onto nitrocellulose, and probed
with anti–erbB2, anti–erbB3 or antiphosphotyrosine antibodies. Proteins
were visualized by addition of HRP goat anti–rabbit Ig and enhanced
chemiluminescence reagents according to the manufacturer’s instructions
(Amersham Pharmacia Biotech).
The time course of GGF-induced tyrosine phosphorylation was ana-
lyzed by treating myelinated cocultures with 200 ng/ml GGF in C media
with ascorbic acid for 0, 1, 2.5, 5, 10, and 30 min at 37
 
8
 
C. The cocultures
were lysed and processed for Western blotting as described above.
 
Kinase Assays
 
Myelinated cocultures were maintained in N2 media for 15 h, and then
treated with or without 200 ng/ml GGF for 10 min at 37
 
8
 
C. Immunopre-
cipitation and measurement of MAP kinase and PI 3-kinase activities
were performed as described previously (Canoll et al., 1999).
 
Results
 
GGF and FGF-2 Inhibit Myelination
 
To determine whether neuregulin-1 regulates Schwann cell
differentiation, we examined the effects of exogenous GGF
on myelination in neuron-Schwann cell cocultures. Cocul-
tures were maintained for 1 wk or longer in media contain-
Figure 1. GGF and FGF-2 inhibit myelination.
(A–F) Schwann cell-neuron cocultures were
grown in myelin-promoting media without (A
and B) or with 20 (C and D) or 200 (E and F) ng/
ml GGF and maintained for 7 d. The cocultures
were fixed and stained for MBP (A, C, and E)
and Hoechst dye to visualize Schwann cell nuclei
(B, D, and F). GGF strikingly inhibited myelina-
tion in a dose-dependent manner. Bar, 100 mm.
(G and H) Schwann cell-DRG neuron cocultures
were switched to myelin-promoting media with
different concentrations of GGF (G) or FGF-2
(H) and maintained for 10 d. Cultures were fixed
and stained for MBP and the numbers of myelin
sheaths per high-powered field were counted.
The mean values and SEM for each GGF and
FGF-2 concentration from two representative
experiments are shown. The number of myelin
sheaths in the cultures treated with either GGF
or FGF-2 was significantly lower than that in
control cultures (P # 0.005). 
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ing serum and ascorbate to promote myelination with or
without the addition of 20 or 200 ng/ml of GGF (corre-
sponding to 
 
z
 
0.25 and 2.5 nM, respectively). Cultures were
fixed and myelin sheaths were visualized by staining for
MBP (Fig. 1). Results demonstrate that GGF strikingly in-
hibited myelination in a dose-dependent manner. Micro-
graphs of representative cocultures demonstrating MBP
expression (Fig. 1, A, C, and E) and the nuclei from corre-
sponding fields (B, D, and F) are shown. Control cultures
(Fig. 1, A and B) demonstrated numerous myelin sheaths;
cultures treated with 20 ng/ml (C and D) or 200 ng/ml (E
and F) of GGF demonstrated substantial (
 
.
 
50%) or essen-
tially complete inhibition of myelination, respectively.
These results are quantitated in Fig. 1 G. This inhibition of
myelination was contingent upon continued GGF treat-
ment. Cultures treated for 21 d continued to demonstrate
partial or complete inhibition of myelination with 20 or 200
ng/ml of GGF; removal of GGF from the media at any
point led to normal myelination (data not shown). These
results indicate that GGF reversibly inhibits myelination.
We have previously demonstrated that TGF-
 
b
 
1, which
is mitogenic for isolated Schwann cells, also inhibits my-
elination in vitro (Einheber et al., 1995). To examine
whether other Schwann cell mitogens inhibit myelination,
we performed a similar analysis with FGF-2. Fig. 1 H re-
veals that FGF-2 was an equally potent inhibitor of my-
elination. Addition of 10 ng/ml (corresponding to 
 
z
 
0.5 nM)
partially inhibited and 100 ng/ml of FGF-2 essentially
completely blocked myelin formation. Taken together,
these data demonstrate that a variety of Schwann cell mi-
togens inhibit myelination.
To investigate the mechanism by which GGF blocks my-
elination, we examined basal lamina formation and the ul-
trastructure of treated and control cultures (Fig. 2). Basal
lamina formation appeared to be unaffected based on the
intensity of laminin staining (Fig. 2, A and B). There was a
striking change in the organization of the cultures, how-
ever. In control cultures, the basal lamina frequently sur-
rounded Schwann cells that were longitudinally oriented
in an apparent 1:1 relationship with an axon (Fig. 2 A, ar-
rows). In contrast, Schwann cells in the treated cultures
apparently failed to form a 1:1 relationship with axons de-
spite expressing significant amounts of laminin at their
surfaces (Fig. 2 B). EM analysis confirmed that GGF in-
hibited the segregation of neurites by Schwann cells. Fig. 2
C shows a control culture in which axons (*) were en-
sheathed by Schwann cell processes; in other fields, axons
were in the early stages of myelination. In contrast, in the
GGF-treated cultures, axonal ensheathment was limited
and fibers were rarely segregated in a 1:1 relationship (Fig.
2 D). In both control and treated cultures, a well-formed
basal lamina was present at the abaxonal Schwann cell sur-
face, consistent with the laminin staining (Fig. 2, C and D,
arrows). These results indicate that the failure of Schwann
Figure 2. GGF inhibits en-
sheathment but not basal lam-
ina formation. Cocultures were
maintained in myelin-promoting
media without (A and C) or with
200 ng/ml GGF (B and D). One
set of cultures was fixed after
11 d and laminin expression was
visualized by immunofluores-
cence (A and B). In control co-
cultures, large axons have formed
an apparent 1:1 relationship with
Schwann cells and are sur-
rounded by basal lamina tubes
(arrows); such laminin tubes are
absent in the treated cultures. A
second set of cultures was fixed
after 1 wk and analyzed by elec-
tron microscopy (C and D). In
the control cultures, several axons
(*) are segregated by Schwann
cell processes, whereas, in the
GGF-treated cultures, axons
were unensheathed despite the
presence of a normal basal lamina
(arrow). Bar, 50 mm (A and B)
and 0.2 mm (C and D). 
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cells to ensheathe axons did not result from an effect of
GGF on basal lamina formation.
 
GGF Induces Demyelination
 
We next analyzed the effects of GGF on cocultures in
which myelin had already formed. Treatment of estab-
lished, myelinated cocultures with GGF for 2 or 3 d re-
sulted in striking demyelination. Fig. 3 A shows an immu-
nofluorescence micrograph of a representative field from
a myelinated coculture, and B shows another coculture un-
dergoing substantial demyelination after 3 d of continuous
treatment with 200 ng/ml of GGF. The demyelinating ef-
fects of GGF were dose dependent (Fig. 3 C). Significant
demyelination was observed with 2 d of treatment even at
20 ng/ml; more extensive demyelination was evident at
higher concentrations. At GGF concentrations of 200 ng/
ml, 
 
z
 
75% of the myelin sheaths degenerated; the remain-
ing sheaths displayed no obvious morphological defects.
While this effect was most robust with continuous treat-
ment, nearly comparable demyelination was observed af-
ter only 30 min of GGF treatment followed by its removal
(data not shown). Finally, treatment with either FGF-2 (10
and 100 ng/ml) or TGF-
 
b
 
1 (10 and 100 ng/ml) did not in-
duce obvious myelin sheath degeneration, indicating this
effect was specific to the neuregulins (data not shown).
Fibers undergoing demyelination were initially charac-
terized by crenated myelin sheaths followed by overt my-
elin breakdown and ovoid formation. Degeneration of
some myelin sheaths was already apparent after 24 h of
treatment, but in most cases maximal demyelination oc-
curred between 36 and 48 h of treatment. Myelin debris
was then rapidly cleared and, by 72 h, was substantially ab-
sent from the cultures. Demyelination often began at one
end of the myelin sheath, progressing from the paranodal
region to the Schwann cell internode (data not shown). To
analyze this effect further, control and treated cultures
were examined by electron microscopy (Fig. 4). In general,
we observed significant amounts of myelin debris within
myelin segments. Some of these appeared to be present
within vacuoles; they were present both in the internode
and the paranodal region (Fig. 4 C). These results suggest
that Schwann cells are able to clear segments of the myelin
sheath while other regions remain remarkably intact.
Demyelination appeared to be a direct, nontoxic effect of
GGF on the Schwann cells. Axons associated with degener-
ating myelin sheaths were intact as indicated by continuous
neurofilament immunoreactivity (data not shown). In addi-
tion, GGF treatment did not increase Schwann cell or neu-
ron apoptosis based on TdT-mediated dUTP nick-end la-
beling analysis (data not shown). Consistent with the lack
of toxicity, the effects of GGF were reversible, with cocul-
tures remyelinating efficiently even after 1 mo of continu-
ous GGF treatment was discontinued (data not shown).
Taken together, these studies indicate that the demyelina-
tion resulting from GGF treatment is specific, reversible,
and likely to be a direct effect on the Schwann cell.
 
GGF Promotes the Dedifferentiation of Myelinating 
Schwann Cells
 
Previous studies have shown that GGF induces oligoden-
drocyte progenitors that have differentiated in culture to
downregulate their expression of MBP and revert to an
earlier stage in their lineage (Canoll et al., 1999). To deter-
mine whether GGF similarly induces Schwann cell dedif-
ferentiation, we analyzed its effects on the expression of
SCIP, a POU-domain transcription factor that is upregu-
lated in vivo at the promyelinating stage and downregu-
lated during myelination (Zorick et al., 1996; Arroyo et al.,
Figure 3. GGF causes demyelination. Immunofluorescence micrographs of cocultures
that had myelinated for 3 wk demonstrating normal myelination in control cultures (A)
or substantial demyelination in companion cultures after 3 d of treatment with 200
ng/ml GGF. The mean percentage of damaged myelin sheaths in the cultures treated
with GGF for 2 d was significantly higher than that in control cultures (P , 0.0001)
(C). The mean values and SEM presented for each GGF concentration are from 12
random fields pooled from a representative experiment. Bar, 100 mm. 
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1998). Consistent with previous findings in vivo, SCIP was
expressed at high levels in the nuclei of Schwann cells be-
fore myelination (Fig. 5 A) and was substantially downreg-
ulated in the nuclei of mature, myelinating Schwann cells
(outlined in A and B). When GGF was added to my-
elinated cocultures for 3 d, there was a dramatic increase
in SCIP expression in myelin-related Schwann cells, includ-
ing those associated with apparently intact as well as with
degenerating myelin sheaths (outlined in C and D). These
results indicate that GGF induces myelinated Schwann
cells to dedifferentiate to the promyelinating stage.
 
GGF-induced Demyelination Does Not 
Require Proliferation
 
To determine whether GGF inhibited myelination, or pro-
moted demyelination, by first inducing Schwann cell pro-
liferation, we incubated cocultures with BrdU and GGF.
We first asked whether GGF had any effect on the rate of
proliferation during early stages of myelination, when
some Schwann cells were still dividing in association with
axons. GGF did not further increase the labeling index of
Schwann cells proliferating in association with neurons, al-
though it was mitogenic for isolated Schwann cells in-
cluded as a positive control (data not shown). Thus, prolif-
eration was 
 
z
 
20% after 1 d and 10% after 3 d of coculture
with neurons, with or without supplemental GGF. These
results suggest that neuregulin levels do not limit the pro-
liferation rate of Schwann cells associated with neurites.
We next examined whether GGF could induce the pro-
liferation of post-mitotic, myelinating Schwann cells. To
this end, cultures that had been myelinating for 3 wk were
continuously treated with GGF for either 36 or 48 h in the
presence of BrdU; cultures were then double stained for
BrdU and MBP to identify myelinating or previously my-
Figure 4. Ultrastructure of control and GGF-treated cocultures. Schwann cell-DRG neuron cocultures that had myelinated for 3 wk
were maintained for an additional 3 d without (A) or with (B and C) 200 ng/ml GGF. The cocultures were then fixed and processed for
electron microscopy. (A) Longitudinal section through a control internode, (B) sections of two Schwann cells; note the presence of nu-
merous myelin inclusions (arrows). (C) Section through a paranode that contains a myelin inclusion (arrow) and an abnormal folding of
the myelin sheath. Bars, 0.2 mm.
Figure 5. GGF causes dedifferen-
tiation of myelinating Schwann
cells. Cocultures that had my-
elinated for 3 wk were main-
tained for an additional 3 d with-
out (A and B) or with (C and D)
200 ng/ml GGF. Cocultures
were then fixed and stained for
SCIP (red) and MBP (green) (A
and C); staining of nuclei of the
same fields is also shown (B and
D). GGF treatment significantly
increased SCIP expression in
Schwann cell nuclei associated
with myelin sheaths, several of
which exhibit partial loss of my-
elin at one or both ends. The nu-
clei of myelinating Schwann cells
are outlined; a premyelinating
Schwann cell nucleus in the con-
trol culture is indicated with an
arrow (A). Bar, 50 mm. 
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elinated cells. In the case of MBP
 
1
 
 cells, we further distin-
guished between cells with an intact myelin sheath and
those with either moderate or advanced demyelination.
Results are summarized in Table I.
GGF induced a significant, approximately fourfold in-
crease in the overall rate of Schwann cell proliferation,
which is normally quite low in these mature cultures (i.e.,
from 1.4 to 6.4% after 36 h of BrdU incorporation). When
MBP
 
1
 
 Schwann cells were analyzed, the mitogenic effects
of GGF depended on the extent of demyelination. A small
percentage of Schwann cells with apparently intact myelin
sheaths were BrdU
 
1
 
 in the treated cultures. As myelinat-
ing Schwann cells normally do not proliferate (Salzer and
Bunge, 1980; see also Fig. 6 A), a labeling index of 3% in
such cells is significant. These results indicate that prolifer-
ation of myelinating Schwann cells can occur in the ab-
sence of obvious demyelination. Cells with myelin sheaths
in late stages of degeneration proliferated the most exten-
sively in response to GGF treatment, exhibiting a labeling
index of 27%; several examples are shown in Fig. 6 C.
 
Strikingly, most Schwann cells, even those with significant
myelin degeneration, did not proliferate during the 36-h
treatment period; thus, 97% of cells with moderate and
73% of those with advanced myelin sheath degenera-
tion remained unlabeled (Table I). The latter results indi-
cate that GGF-induced demyelination does not require
Schwann cells to re-enter the cell cycle. After 48 h of GGF
treatment, demyelination was more extensive and the la-
beling index increased to 
 
z
 
50% in those cells with exten-
sive myelin sheath degeneration. Even at this later time
point, however, many Schwann cells with substantial de-
myelination were unlabeled. Taken together, these studies
indicate that demyelination does not require Schwann cell
proliferation and that proliferation typically occurs when
demyelination is quite advanced.
 
Phosphorylation of GGF Receptors and Activation of 
Signaling Pathways
 
Finally, we characterized the effects of GGF on neuregulin
receptors and downstream signaling pathways. Detergent
lysates were prepared directly from Schwann cell, DRG
neuron, premyelinated, and myelinated cocultures or after
treating these cultures with 200 ng/ml of GGF for 2.5 min.
Lysates were fractionated by SDS-PAGE, blotted onto ni-
trocellulose, and probed with anti–erbB2, anti–erbB3, or
antiphosphotyrosine antibodies. As previously reported
(Levi et al., 1995; Canoll et al., 1996), erbB2 and erbB3
were robustly expressed in Schwann cells (Fig. 7 A). GGF
increased the tyrosine phosphorylation of p185, which cor-
responds to the expected mol wt of erbB2 and erbB3 (Fig.
7 A). In contrast, minimal erbB2 and erbB3 were detected
by Western blotting of neurons, although low-level erbB2
expression was observed by immunofluorescence (data
not shown). Consistent with this limited erbB expression,
no phosphorylation of p185 was observed after GGF treat-
ment of the DRG neuron cultures.
 
Table I. Relationship between Demyelination and Schwann 
Cell Proliferation
 
GGF
Schwann
cell
Cells with intact
myelin sheaths
Cells with moderate
degeneration
Cells with extensive
degeneration
 
ng/ml
 
0 1.4 
 
6
 
 0.4 0 0 0
200 6.4 
 
6
 
 0.8* 3.0 
 
6
 
 2.1 2.8 
 
6
 
 2.8 27 
 
6
 
 8.1*
 
Myelinated cocultures were incubated with BrdU for 36 h in media with or without 200
ng/ml GGF. The cocultures were then fixed and stained for BrdU, MBP, and Hoechst.
*Proliferation was increased significantly the GGF-treated cultures for the total popu-
lation os Schwann cells (
 
P
 
 
 
,
 
 0.0001) and for cells with myelin sheaths. Analysis of
MBP
 
1
 
 Schwann cells indicated that proliferation was significantly increased in cells
with sheaths undergoing extensive (
 
.
 
50%) degeneration (
 
P
 
 
 
, 
 
0.005) in the GGF-
treated cultures. Cells with moderate degeneration (i.e., 
 
,
 
50%) also showed increased
proliferation that did not reach statistical significance. The mean values and SEM pre-
sented for each GGF concentration are from 12 random fields pooled from a represen-
tative experiment.
Figure 6. Demyelination and pro-
liferation are not obligately linked.
Myelinated cocultures were incu-
bated with BrdU for 36 h in media
without (A and B) or with (C and
D) 200 ng/ml GGF. The cocultures
were then fixed and stained for
BrdU (green) and MBP (red);
nuclei are stained with Hoechst
(blue). In control cultures, my-
elinating Schwann cells do not
incorporate BrdU (four represen-
tative nuclei are encircled in A and
B), whereas BrdU-positive nuclei
are relatively common in GGF-
treated cultures, typically in cells
undergoing extensive demyelina-
tion (C, arrowhead and inset).
Note also that the nuclei of several
degenerating myelin sheaths are
BrdU2 (*). This increase in BrdU
labeling was associated with actual
Schwann cell mitosis as BrdU1 nu-
clei were also present as doublets
(C, inset). Bar, 40 mm. 
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In cocultures of neurons and Schwann cells, erbB2 and
erbB3 continued to be expressed at substantial levels in
both premyelinating (i.e., cultures maintained in the ab-
sence of ascorbate to prevent basal lamina formation) and
myelinating cocultures (Fig. 7 A). As the myelinated cul-
tures are heterogeneous, this high level expression of
erbB2 and erbB3 may reflect expression by ensheathing
Schwann cells, by myelinating Schwann cells, or both. Basal
levels of p185 phosphorylation were observed in the pre-
myelinated and myelinated cocultures, but not in Schwann
cells alone; addition of GGF substantially increased the
phosphorylation of p185 in all Schwann cell culture condi-
tions (Fig. 7 A). Of interest, GGF also induced the tyrosine
phosphorylation of a 120-kD protein (p120) in myelinated
cocultures, but not in Schwann cells or premyelinating co-
cultures (Fig. 7 A). Fig. 7 B reveals that p185 phosphoryla-
tion increased to near maximal levels after 1 min of GGF
treatment; this level was sustained for at least 30 min of
GGF treatment. In contrast, p120 phosphorylation, al-
though present at 1 min of GGF treatment, reached maxi-
mum levels only after 2.5 min and declined at incubation
times of 10 min or longer. These results suggest that p120
phosphorylation is downstream of erbB phosphorylation.
Preliminary analysis suggested that p120 is distinct from fo-
cal adhesion kinase, c-cbl, and Pyk-2, candidate proteins of
similar mol wt (data not shown).
We next analyzed neuregulin receptor expression and
phosphorylation in myelinating cocultures continuously
treated with GGF. Fig. 7 C demonstrates that erbB3 levels
remain constant, whereas erbB2 levels decreased in a dose-
dependent fashion, although it remained detectable even
in cultures treated with 200 ng/ml of GGF. Surprisingly,
p185 continued to be phosphorylated at high levels despite
the low levels of erbB2; in contrast, phosphorylation of
p120 was no longer detectable after 3 d of GGF treatment.
 
These results indicate that GGF-induced demyelination is
associated with continued erbB phosphorylation.
To investigate the intracellular signaling pathways that
may mediate GGF-induced demyelination, we examined
whether GGF activates PI 3-kinase and MAP kinase in
myelinated cocultures. Myelinating cocultures were lysed
directly or after treatment with 200 ng/ml of GGF for 10
min. Immunoprecipitates were prepared with antiphos-
photyrosine or anti–extracellular signal-regulated kinase-1
and -2 (erk-1 and erk-2) antibodies, and kinase reactions
were performed. GGF induced a 1.5–2-fold activation of
MAP kinase and a 5–6-fold activation of PI 3-kinase (data
not shown). This robust activation of PI 3-kinase suggests
a potential role in mediating GGF-induced demyelination.
 
Discussion
 
While neuregulin-1 has a crucial role in peripheral nervous
system development (Adlkofer and Lai, 2000), its role,
and that of other growth factors, in the later events of pe-
ripheral nerve development remains poorly understood.
In this study, we have demonstrated that GGF, a soluble
neuregulin-1 isoform, blocks axon ensheathment and my-
elination, and leads to extensive demyelination when
added to mature cocultures. These findings suggest a po-
tential role for the neuregulins and other mitogens as in-
hibitors of Schwann cell differentiation, and support their
role in pathologic demyelination as discussed below.
 
Schwann Cells Exit the Cell Cycle in the Presence of 
Saturating Amounts of Neuregulins
 
The neuregulins are known to be major components of
the contact-dependent neurite mitogen that promotes
Schwann cell proliferation during development (Morrissey
et al., 1995). In contrast, the signals that cause Schwann
Figure 7. Expression and ty-
rosine phosphorylation of GGF
receptors. (A) Expression and
phosphorylation of GGF recep-
tors. DRG neurons, Schwann
cells, premyelinated (premy),
and myelinated (my) cocultures
were lysed directly (2) or after
2.5 min of 200 ng/ml GGF treat-
ment (1). 15 mg of each lysate
was fractionated by SDS-PAGE,
blotted onto nitrocellulose, and
probed with anti–erbB2, anti–
erbB3, or antiphosphotyrosine
antibodies. ErbB2 and erbB3
were expressed by Schwann cells
(c and d) and in the cocultures
(e–h). Note that while GGF acti-
vated p185 in all cultures contain-
ing Schwann cells, p120 was only
activated in the myelinated co-
cultures (h); a constitutively
phosphorylated band of z140 kD was present in all the lanes. (B) Time course of phosphorylation. Myelinated cocultures were lysed ei-
ther directly or at varying times after treatment with 200 ng/ml GGF. Lysates were fractionated and blotted as described in A, and
probed with antiphosphotyrosine antibodies. Both p185 and p120 were rapidly tyrosine phosphorylated and continued to be phosphory-
lated after 30 min of GGF treatment. (C) Expression and phosphorylation of GGF receptors in demyelinating cocultures. Myelinated co-
cultures were maintained for 3 d in media without or with 20 or 200 ng/ml GGF. Protein lysates were prepared, fractionated, blotted, and
probed as described in A. While there was a dose-dependent decrease in erbB2 (top), erbB3 levels were unchanged (middle). (Bottom)
There was a dose-dependent increase in p185 tyrosine phosphorylation in the cocultures treated with GGF for 3 d. 
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cells to exit the cell cycle have not been identified. Poten-
tially, limiting amounts of neuregulins, and/or downregula-
tion of their receptors, could be responsible. To investigate
these possibilities, we added GGF to cocultures either dur-
ing the period of rapid Schwann cell proliferation or in
older, myelinating cultures in which most Schwann cells
had stopped dividing. Addition of GGF did not further in-
crease the mitotic index of Schwann cells rapidly prolifer-
ating in association with neurons (data not shown); pre-
sumably, they were already maximally stimulated by
neuregulins on the neurites (Morrissey et al., 1995). In ma-
ture cocultures that had myelinated for 3 wk, GGF mod-
estly increased the labeling index (Table I) and the result-
ant density of Schwann cells (Fig. 6 D). Even in the
presence of GGF, however, the great majority of the
Schwann cells associated with neurites in mature cultures
did not reenter the cell cycle despite robust erbB phos-
phorylation (Fig. 7). These results suggest that downregula-
tion of neuregulin-erbB signaling between axons and
Schwann cells (discussed further below) only modestly con-
tributes to Schwann cell cycle arrest and that other signals,
such as density-dependent interactions between Schwann
cells, play a more significant role (Casella et al., 2000).
 
Role of the Neuregulins in Regulating Myelination
 
In this report, we have demonstrated that physiologic con-
centrations of GGF and FGF-2 strikingly inhibit myelina-
tion in Schwann cell-neuron cocultures. These results are
consistent with the effects of these mitogens on myelin
protein expression by forskolin-treated Schwann cells
(Morgan et al., 1994; Cheng and Mudge, 1996) and extend
previous studies in which TGF-
 
b
 
 was found to potently
block myelination in cocultures (Einheber et al., 1995;
Guénard et al., 1995). Together, they suggest that mitogen
activation can maintain Schwann cells in a pre- or nonmy-
elinating state and raise the possibility that such mitogens
may correspond to the inhibitory signals that promote the
nonmyelinating phenotype of Schwann cells in unmy-
elinated nerves (Lee et al., 1997). However, as Schwann
cells in the GGF-treated cultures do not ensheathe or seg-
regate axons appropriately (Fig. 2), the neuregulins may
not fully promote the ensheathing phenotype in vivo.
These studies contrast with a recent report (Garratt et
al., 2000b) suggesting that erbB2 promotes myelination. In
particular, mice with a prenatal conditional knockout of
erbB2 exhibited significant hypomyelination, including
thinly myelinated and amyelinated large caliber axons.
Similarly, activation of PI 3-kinase in Schwann cells, which
is largely driven by neuregulin-1 on the axon surface
(Maurel, P., and J. Salzer, unpublished studies), is required
for the early events of myelination but not for myelin
maintenance (Maurel and Salzer, 2000). Both studies do
not distinguish between a role for erbB2 or PI 3-kinase in
establishing initial axon-Schwann cell interactions that are
a prelude to myelination or a direct role during myelina-
tion itself; thus, in the case of the conditional erbB2 knock-
out, it may have been ablated as early as E16. In addition,
erbB2 is present in the abaxonal membrane of myelinating
Schwann cells (Carroll et al., 1997), a distribution we have
also observed in the cocultures (Zanazzi, G., and J. Salzer,
unpublished observations). In this location, erbB2 would
be unlikely to mediate signals from axonal neuregulins, but
rather would be more likely to interact with ligands
 
present in the extracellular matrix, including, potentially,
other members of the EGF superfamily. ErbB2 may also
regulate the activity of integrins (Gambaletta et al., 2000),
which are similarly concentrated in the abaxonal mem-
brane (Einheber et al., 1993) and are required for myelina-
tion (Fernandez-Valle et al., 1994). In the future, studies to
examine directly the requirement for NRG-1 at different
stages of myelination will be of interest.
Taken together, these studies suggest that neuregulin
signaling, in particular activation of PI 3-kinase, is required
to generate Schwann cells and establish axon-Schwann cell
relationships required for the early morphogenetic events
of myelination, whereas, once a full complement of
Schwann cells is generated and organized into a 1:1 rela-
tionship with axons, persistent neuregulin signaling inhib-
its myelination. This provides a mechanism for preventing
Schwann cells whose abaxonal surface is in contact with an
unensheathed nerve fiber from forming myelin, ensuring
that myelination would only commence once all axons are
ensheathed. These results are also consistent with evidence
that neuregulin signaling is substantially downregulated
during myelination and in the adult. Thus, the levels of
some neuregulin isoforms (Chen et al., 1994; Shinoda et
al., 1997), erbB2 (Cohen et al., 1992) and erbB3 (Grinspan
et al., 1996), are all downregulated during postnatal devel-
opment, as is CD44, which enhances neuregulin signaling
(Sherman et al., 2000). In agreement, erbB2 is abundantly
phosphorylated in the perinatal sciatic nerve (Grinspan et
al., 1996), but is minimally phosphorylated in the adult
(Grinspan et al., 1996; Kwon et al., 1997). Decreased ex-
pression of the neuregulins, as well as the substantial
downregulation of their receptors, together with the redis-
tribution of these receptors to the abaxonal surface, would
be expected to substantially reduce neuregulin signaling by
axons, thereby allowing myelination to proceed.
 
GGF Activates Mitogen Signaling Pathways and Results 
in Dedifferentiation
 
GGF treatment of myelinating cocultures results in rapid
erbB phosphorylation and activation of the MAP kinase
and PI 3-kinase intracellular signaling pathways. These ini-
tial events are likely to play a key role in subsequent demy-
elination as evidenced by the striking demyelination ob-
served with even a brief 30-min pulse of GGF; in addition,
the dose-dependent increase in the p185 phosphorylation
(Fig. 7) correlated well with the dose-dependent demyelina-
tion (Fig. 3 C). Tyrosine phosphorylation of p185 was rap-
idly followed by phosphorylation and dephosphorylation of
a 120-kD protein. Interestingly, GGF activated p120 phos-
phorylation only in myelinated cocultures, suggesting that
this protein is specifically expressed in myelinating Schwann
cells and may have a role in GGF-induced demyelination.
The identity of this protein, whether it is specifically phos-
phorylated by neuregulins but not other mitogens and
whether it is phosphorylated during demyelination in vivo
are important questions for future investigation.
In contrast to the rapid activation of these signaling
pathways, GGF-induced demyelination was apparent after
a significant lag of 24–36 h, however, presumably reflect-
ing downstream effects including changes in transcription
factor levels and activities. Neuregulins regulate the activ-
ity of several transcription factors (Hagedorn et al., 2000;
Talukder et al., 2000) and result in sustained CREB phos- 
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phorylation in Schwann cells (Tabernero et al., 1998); this
latter effect may relate to the ability of GGF to induce
SCIP expression in myelinating Schwann cells. This induc-
tion indicates that GGF caused the myelinating Schwann
cells to dedifferentiate to the promyelinating stage, which
is characterized by high SCIP expression (Zorick et al.,
1996; Arroyo et al., 1998). Interestingly, GGF blocks the
differentiation of oligodendrocyte progenitors and causes
oligodendrocytes to dedifferentiate to the pro-oligoden-
drocyte stage (Canoll et al., 1996, 1999). Thus the effects
of the neuregulins on oligodendrocytes and Schwann cells
(i.e., promoting the generation of myelinating glial cells
and inhibiting their differentiation) is well conserved be-
tween these two cell types.
An important question is whether altered expression of
transcription factors is mechanistically related to the de-
myelination observed with GGF treatment. SCIP inhibits
the transcription of P0 (Monuki et al., 1990), and its in-
creased expression might therefore affect myelin produc-
tion and stability; it also increases transiently during Wal-
lerian degeneration (Zorick et al., 1996). However, as
reduction of myelin protein expression alone is insufficient
to induce Wallerian degeneration (Toews et al., 1997), the
neuregulins may actively promote myelin sheath degener-
ation by other mechanisms.
 
Relationship of Proliferation to Demyelination
 
In addition to demyelination, GGF induced Schwann cell
proliferation in the myelinating cultures. Demyelination
itself is not dependent on earlier Schwann cell prolifera-
tion, as many cells that did not proliferate during the treat-
ment period exhibited substantial myelin degeneration
(Fig. 6 C). Indeed the majority of demyelination occurred
in BrdU
 
2
 
 cells. Proliferation of previously myelinating
Schwann cells was apparent by 36 h and increased further
at 48 h of GGF treatment; at this stage, demyelination was
quite advanced, suggesting that proliferation may occur as
a later event. In agreement, Schwann cells that prolifer-
ated were at advanced stages of myelin degeneration (Ta-
ble I). These results suggest that either breakdown prod-
ucts of myelin are themselves mitogenic (Salzer and
Bunge, 1980; Bigbee et al., 1987) or, conversely, that my-
elin debris must be substantially cleared and Schwann
cells must dedifferentiate before GGF is able to induce
Schwann cells to reenter the cell cycle (Fernandez-Valle et
al., 1995). We now favor the latter possibility as the occa-
sional Schwann cell that spontaneously demyelinates in
control cultures (i.e., in the absence of GGF) almost never
proliferates, even when demyelination is advanced (Za-
nazzi, G., and J. Salzer, unpublished observations). These
results also suggest that, as myelin debris is cleared and
possibly erbB expression is upregulated, GGF is able to
drive Schwann cell proliferation more efficiently.
 
Implications for Peripheral Neuropathies and
Wallerian Degeneration
 
Demyelination and Schwann cell proliferation are also
hallmarks of Wallerian degeneration and hypertrophic
demyelinating neuropathies (reviewed in Asbury and
Johnson, 1978; Scherer and Salzer, 1996). The signals that
initiate demyelination in Wallerian degeneration and in
 
various neuropathies are poorly understood. In the case of
Wallerian degeneration, two distinct hypotheses have
been proposed: disruption of the nerve fiber results in loss
of axonal signals required to maintain the myelin sheaths
or, alternatively, positive signals released as a conse-
quence of axotomy initiate this process (Scherer and
Salzer, 1996). In support of the latter possibility, diffusible
mitogens appear to be released within the endoneurium
that stimulate proliferation of a variety of cell types, in-
cluding ensheathing Schwann cells associated with axons
(Griffin et al., 1987). In this study, we have demonstrated
that increased neuregulin activity, even in the presence of
intact axons, is sufficient to induce important aspects of
Wallerian degeneration, providing an experimental coun-
terpart to these in vivo findings.
These results are also consistent with earlier studies that
suggested a potential role for the neuregulins during Walle-
rian degeneration. Neuregulin and erbB expression by
Schwann cells increases substantially during Wallerian de-
generation (Cohen et al., 1992; Carroll et al., 1997) and
demyelination (Hall et al., 1997), suggesting a potential
autocrine signaling mechanism. Importantly, erbB2 phos-
phorylation also increases in the distal stump after nerve
transection (Kwon et al., 1997). However, while the in-
creases in neuregulin and erbB expression and erbB2 phos-
phorylation occur during the period of Schwann cell prolif-
eration, they peak later and persist after this proliferation
has declined (Carroll et al., 1997; Kwon et al., 1997). Thus,
while neuregulin receptor activation is likely to potentiate
Schwann cell proliferation, dedifferentiation, and demyelin-
ation in the distal stump, the precise role of this activation,
particularly during later stages of Wallerian degeneration, is
unclear. Other possible roles include enhancing nerve fiber
regeneration by promoting Schwann cell migration into the
gap between the proximal and distal stumps (Mahanthappa
et al., 1996) and by increasing expression of neurotrophins
available to regenerating axons (Verdi et al., 1996). Results
from this study also raise the possibility that neuregulins
promote the clearance of myelin debris.
In summary, these results suggest that the neuregulins
and erbBs play an important role not only in the genera-
tion of Schwann cells during development but also in later
events of peripheral nerve development and in the adult.
Downregulation of neuregulin signaling may be required
for myelination to proceed, whereas persistent activity
could bias the Schwann cells to the nonmyelinating pheno-
type. Our results also suggest that activation of mitogen
signaling pathways by neuregulins, and possibly other mi-
togens, in pathologic settings may contribute to dymy-
elination and the events of peripheral nerve degeneration.
Future studies focusing on the role of mitogen signaling
pathways during demyelination and the role of the neureg-
ulins in Wallerian degeneration and hypertrophic periph-
eral neuropathies should further clarify their precise role
in these processes.
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